Clinical Trial Update: Initial Clinical and CBCT Outcomes of Enamel Matrix Derivative-Based Regenerative Therapy in Vertical Bone Defects [NA]

View source ↗

Summary

This clinical trial reports initial clinical and CBCT outcomes for regenerative therapy using enamel matrix derivative to treat vertical alveolar bone defects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alveolar Bone Loss
• Periodontal Disease

Drugs mentioned

• Emdogain (Enamel Matrix Derivative)

Snippet

Sponsor: Tsvetalina Gerova-Vatsova | Conditions: Vertical Alveolar Bone Loss | NA | Status: COMPLETED